Business Context and Reporting Period
This Form 8-K is a current report filed by OncoCyte Corporation (noted as Insight Molecular Diagnostics Inc. in metadata) on November 18, 2017. The filing addresses a specific corporate governance event rather than periodic financial results.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure regarding the departure of a director and contains no financial statements or performance data.
Material Changes
The material change reported is the resignation of Don M. Bailey, age 71, from the Board of Directors effective November 18, 2017. The resignation was tendered for personal reasons. The Board intends to recruit a new independent director to fill the resulting vacancy.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements disclaiming any obligation to update such statements. It references risk factors detailed in the company's Form 10 filed with the SEC. No specific operational guidance or outlook is provided in this document.
Key Facts for Investor Verification
- Don M. Bailey resigned from the Board of Directors on November 18, 2017, for personal reasons.
- The Board plans to recruit a replacement independent director.
- The registrant is identified as OncoCyte Corporation in the filing text.
- No financial performance data is included in this specific 8-K filing.